Mechanistic studies to develop a polysaccharide degradation signature (PDS) and its application in improving host health

开发多糖降解特征(PDS)的机制研究及其在改善宿主健康中的应用

基本信息

  • 批准号:
    10643928
  • 负责人:
  • 金额:
    $ 51.12万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-15 至 2025-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT The human colon harbors a large number of microorganisms that collectively are referred to as the colonic microbiome. The microbes in the colonic microbiome are dominated by bacteria of the phyla Bacteroidetes and Firmicutes. Among the Bacteriodetes, Prevotella spp. and Bacteroides spp. abound in the colonic environment and have evolved a complex protein machinery that allows them to harvest energy from both host undegradable polysaccharides in the diet and host derived-glycans, such as mucin. Central to the mechanism underlying polysaccharide degradation by the Bacteroidetes is the Polysaccharide Degradation Locus (PUL) or Loci (PULs) present on their genomes. The PULs are composed of gene clusters that encode proteins that enable the Bacteroidetes to sense, transport, and degrade diverse polysaccharides to their unit sugars for fermentation. A large protein, known as the Hybrid Two Component System (HTCS), is conserved in the PULs of the Bacteroidetes and functions by sensing either a polysaccharide or its oligosaccharides to turn on the expression of the hydrolytic enzymes and their associated transporters. In this proposal, we demonstrate that indeed the Bacteroidetes HTCS contain sensor modules that sense unique polysaccharides or their degradative products in the colonic environment. Thus, we hypothesized that the diverse sensors in the HTCS polypeptides collectively can serve as a proxy for polysaccharide sensing in the colon of an individual. We have designated this proxy as the Polysaccharide Degradation Signature or PDS. By using more than 3000 HTCS sequences in the publicly available databases, we constructed a phylogenetic tree that appeared to cluster the sensor modules into different branches. Among host undegradable polysaccharides found in human diets, such as wheat, barley, rice and oats, is arabinoxylan. We, therefore, used growth on arabinoxylan and transcriptomic analysis to determine the PULs that target soluble arabinoxylan and insoluble arabinoxylan degradation, respectively, in three members of the human colonic Bacteroidetes. Our data showed that clusters in our phylogenetic tree or PDS can be matched to arabinoxylan sensing and metabolism. Interestingly, we also discovered that the Bacteroides spp that metabolize complex arabinoxylan release the plant phenolic compound ferulic acid and that the compound accumulates in the spent medium. Ferulic acid is known to have antioxidant effects and also to protect against mechanosensory hair loss. We will, therefore, determine whether a synbiotic of complex arabinoxylan and arabinoxylan-metabolizing Bacteroidetes has the capacity to confer protection against mechanosensory hair loss in germ-free zebrafish. Confirmation of this observation will allow us, through transcriptomics analysis, to determine the underlying molecular mechanisms for this protection. Furthermore, we will use biochemical and structural analyses to completely characterize the mechanism of arabinoxylan degradation by the human colonic Bacteroidetes. We also anticipate that our development of the PDS will allow rational manipulation of the polysaccharides sensed by an individual’s microbiome for health and nutritional benefits.
项目摘要/摘要 人的结肠含有大量的微生物,这些微生物统称为结肠 微生物组。结肠微生物群中的微生物主要是拟杆菌门的细菌和 菲米库斯。在细菌中,普雷沃特氏菌(Prevoella spp.)和拟杆菌属(Bacteroids spp.)在结肠环境中大量存在 并进化出一种复杂的蛋白质机制,使它们能够从两个不可降解的宿主中获取能量 饮食中的多糖和宿主衍生的多糖,如粘蛋白。是潜在机制的核心 拟杆菌对多糖的降解是多糖降解位点(PUL)或PULS(PULS) 存在于它们的基因组中。PULs是由基因簇组成的,这些基因簇编码的蛋白质使 拟杆菌能感应、运输和降解不同的多糖为单位糖以供发酵。一个 大型蛋白质,被称为混合双组分系统(HTCS),在PULS中保守 类杆菌及其功能是通过感知多糖或其低聚糖来开启表达 水解酶及其相关的转运体。在这项提案中,我们确实证明了 类杆菌HTC含有感测独特的多糖或其降解产物的传感器模块 在结肠环境中。因此,我们假设HTCS多肽中的不同感受器共同作用 可以作为个体结肠中多糖感知的代理。我们已将此代理指定为 多糖类降解特征或PDS。通过使用公开的3000多个HTCS序列 在现有的数据库中,我们构建了一个系统发育树,似乎将传感器模块聚为 不同的分支机构。在人类饮食中发现的宿主不可降解的多糖中,如小麦、大麦、大米 燕麦,是阿拉伯木聚糖。因此,我们使用阿拉伯木聚糖生长和转录分析来确定 分别以可溶性阿拉伯木聚糖和不溶性阿拉伯木聚糖降解为目标的PULS在三个 人类结肠类杆菌的成员。我们的数据显示,在我们的系统发育树或PDS中的集群 可以匹配阿拉伯木聚糖的感官和新陈代谢。有趣的是,我们还发现类杆菌 代谢复合阿拉伯木聚糖的SPP释放植物酚类化合物阿魏酸,并 化合物在废弃的介质中积累。众所周知,阿魏酸具有抗氧化作用,还可以保护 防止机械性脱发。因此,我们将确定一种复杂的阿拉伯木聚糖的合生体 而代谢阿拉伯木聚糖的类杆菌具有保护头发免受机械感觉的能力。 无菌斑马鱼的损失。证实这一观察结果将使我们能够通过转录组分析, 确定这种保护的潜在分子机制。此外,我们将使用生化和 人结肠对阿拉伯木聚糖降解机理的结构分析 拟杆菌。我们还预计,我们开发的PDS将允许合理地操纵 个人微生物群感受到的对健康和营养有益的多糖。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ISAAC CANN其他文献

ISAAC CANN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ISAAC CANN', 18)}}的其他基金

Mechanistic studies to develop a polysaccharide degradation signature (PDS) and its application in improving host health
开发多糖降解特征(PDS)的机制研究及其在改善宿主健康中的应用
  • 批准号:
    10798637
  • 财政年份:
    2020
  • 资助金额:
    $ 51.12万
  • 项目类别:
Mechanistic studies to develop a polysaccharide degradation signature (PDS) and its application in improving host health
开发多糖降解特征(PDS)的机制研究及其在改善宿主健康中的应用
  • 批准号:
    10260593
  • 财政年份:
    2020
  • 资助金额:
    $ 51.12万
  • 项目类别:
Mechanistic studies to develop a polysaccharide degradation signature (PDS) and its application in improving host health
开发多糖降解特征(PDS)的机制研究及其在改善宿主健康中的应用
  • 批准号:
    10099985
  • 财政年份:
    2020
  • 资助金额:
    $ 51.12万
  • 项目类别:
Mechanistic studies to develop a polysaccharide degradation signature (PDS) and its application in improving host health
开发多糖降解特征(PDS)的机制研究及其在改善宿主健康中的应用
  • 批准号:
    10407070
  • 财政年份:
    2020
  • 资助金额:
    $ 51.12万
  • 项目类别:
DOMAIN ANALYSIS OF M ACEIVORANS REPLICATION PROTEIN A 1
M ACEIVORANS 复制蛋白 A 1 的结构域分析
  • 批准号:
    7357984
  • 财政年份:
    2006
  • 资助金额:
    $ 51.12万
  • 项目类别:
CHARACTERIZATION OF A NOVEL ZINC FINGER IN THE ARCHAEA
古细菌中新型锌指的表征
  • 批准号:
    7181227
  • 财政年份:
    2005
  • 资助金额:
    $ 51.12万
  • 项目类别:
DOMAIN ANALYSIS OF M ACEIVORANS REPLICATION PROTEIN A 1
M ACEIVORANS 复制蛋白 A 1 的结构域分析
  • 批准号:
    7181229
  • 财政年份:
    2005
  • 资助金额:
    $ 51.12万
  • 项目类别:
NOVEL CARBOHYDRATE BINDING MODULES FROM T POLYSACCHAROLYTICUM
来自 T 多糖的新型碳水化合物结合模块
  • 批准号:
    7181228
  • 财政年份:
    2005
  • 资助金额:
    $ 51.12万
  • 项目类别:

相似海外基金

Disrupting Dogma: Investigating LPS Biosynthesis Inhibition as an Alternative Mechanism of Action of Aminoglycoside Antibiotics
颠覆教条:研究 LPS 生物合成抑制作为氨基糖苷类抗生素的替代作用机制
  • 批准号:
    10653587
  • 财政年份:
    2023
  • 资助金额:
    $ 51.12万
  • 项目类别:
Shaping Next Generation Aminoglycoside Antibiotics for Treatment of Multidrug-Resistant Diseases
打造下一代氨基糖苷类抗生素治疗多重耐药性疾病
  • 批准号:
    10585038
  • 财政年份:
    2023
  • 资助金额:
    $ 51.12万
  • 项目类别:
Creation of Next-generation Aminoglycoside Antibiotics Active against Multidrug-resistant Gram-negative Bacteria
开发对多重耐药革兰氏阴性菌具有活性的下一代氨基糖苷类抗生素
  • 批准号:
    20K06982
  • 财政年份:
    2020
  • 资助金额:
    $ 51.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Shaping Next Generation Aminoglycoside Antibiotics for Treatment of Multidrug- Resistant Diseases
打造下一代氨基糖苷类抗生素治疗多重耐药性疾病
  • 批准号:
    9934590
  • 财政年份:
    2019
  • 资助金额:
    $ 51.12万
  • 项目类别:
Combating Antibiotic Resistance to Aminoglycoside Antibiotics through Chemical Synthesis
通过化学合成对抗氨基糖苷类抗生素的耐药性
  • 批准号:
    392481159
  • 财政年份:
    2017
  • 资助金额:
    $ 51.12万
  • 项目类别:
    Research Fellowships
Shaping Next Generation Aminoglycoside Antibiotics for Treatment of Multidrug-Resistant Diseases
打造下一代氨基糖苷类抗生素治疗多重耐药性疾病
  • 批准号:
    9082038
  • 财政年份:
    2016
  • 资助金额:
    $ 51.12万
  • 项目类别:
Functional analysis of radical SAM enzymes involved in the biosynthesis of aminoglycoside antibiotics
氨基糖苷类抗生素生物合成中自由基SAM酶的功能分析
  • 批准号:
    26410174
  • 财政年份:
    2014
  • 资助金额:
    $ 51.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
EAPSI:Synthesis of Aminoglycoside Antibiotics
EAPSI:氨基糖苷类抗生素的合成
  • 批准号:
    1106886
  • 财政年份:
    2011
  • 资助金额:
    $ 51.12万
  • 项目类别:
    Fellowship Award
Preclinical evaluation of aminoglycoside antibiotics-derived amphiphiles (AADAs)
氨基糖苷类抗生素衍生的两亲物 (AADA) 的临床前评估
  • 批准号:
    185482
  • 财政年份:
    2009
  • 资助金额:
    $ 51.12万
  • 项目类别:
    Operating Grants
AMINOGLYCOSIDE ANTIBIOTICS FOR CYSTIC FIBROSIS
治疗囊性纤维化的氨基糖苷类抗生素
  • 批准号:
    6565399
  • 财政年份:
    2001
  • 资助金额:
    $ 51.12万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了